Compile Data Set for Download or QSAR
Report error Found 83 Enz. Inhib. hit(s) with Target = 'Gag-Pol polyprotein [489-587,Q496K]'
TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293304(US10106504, Example 41)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293313(US10106504, Example 50)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293312(US10106504, Example 49)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293311(US10106504, Example 48)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293310(US10106504, Example 47)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293309(US10106504, Example 46)
Affinity DataEC50:  61nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293309(US10106504, Example 46)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293308(US10106504, Example 45)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293307(US10106504, Example 44)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293306(US10106504, Example 43)
Affinity DataEC50:  550nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293305(US10106504, Example 42)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293314(US10106504, Example 51)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293303(US10106504, Example 40)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293302(US10106504, Example 39)
Affinity DataEC50:  24nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293302(US10106504, Example 39)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293301(US10106504, Example 38)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293300(US10106504, Example 37)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293299(US10106504, Example 36)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293298(US10106504, Example 35)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293297(US10106504, Example 34)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293296(US10106504, Example 33)
Affinity DataEC50:  282nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293323(US10106504, Example 60)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293331(US10106504, Example 68)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293330(US10106504, Example 67)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293329(US10106504, Example 66)
Affinity DataEC50:  6nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293329(US10106504, Example 66)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293328(US10106504, Example 65)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293327(US10106504, Example 64)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293326(US10106504, Example 63)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293325(US10106504, Example 62)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293324(US10106504, Example 61)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293323(US10106504, Example 60)
Affinity DataEC50:  3nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293296(US10106504, Example 33)
Affinity DataEC50:  550nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293322(US10106504, Example 59)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293321(US10106504, Example 58)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293320(US10106504, Example 57)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293319(US10106504, Example 56)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293318(US10106504, Example 55)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293317(US10106504, Example 54)
Affinity DataEC50:  8nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293317(US10106504, Example 54)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293316(US10106504, Example 53)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293315(US10106504, Example 52)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293270(US10106504, Example 7)
Affinity DataEC50:  545nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293279(US10106504, Example 16)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293278(US10106504, Example 15)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293277(US10106504, Example 14)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293276(US10106504, Example 13)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293275(US10106504, Example 12)
Affinity DataEC50:  7nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293275(US10106504, Example 12)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293274(US10106504, Example 11)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Displayed 1 to 50 (of 83 total ) | Next | Last >>
Jump to: